Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy ADMA Biologics stock
Learn how to easily invest in ADMA Biologics stock.
ADMA Biologics Inc is a biotechnology business based in the US. ADMA Biologics shares (ADMA) are listed on the NASDAQ and all prices are listed in US Dollars. ADMA Biologics employs 527 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in ADMA Biologics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ADMA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
ADMA Biologics stock price (NASDAQ: ADMA)Use our graph to track the performance of ADMA stocks over time.
ADMA Biologics shares at a glance
|Latest market close||$1.98|
|52-week range||$1.01 - $2.32|
|50-day moving average||$1.95|
|200-day moving average||$1.57|
|Wall St. target price||$5.13|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.49|
Buy ADMA Biologics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ADMA Biologics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ADMA Biologics price performance over time
|1 week (2022-06-24)||2.06%|
|1 month (2022-05-31)||-3.41%|
|3 months (2022-03-29)||N/A|
|6 months (2021-12-29)||N/A|
|1 year (2021-07-02)||27.74%|
|2 years (2020-07-02)||-31.49%|
|3 years (2019-07-02)||3.86|
|5 years (2017-06-30)||3.7|
ADMA Biologics financials
|Revenue TTM||$94 million|
|Gross profit TTM||$1.2 million|
|Return on assets TTM||-13.16%|
|Return on equity TTM||-65.38%|
|Market capitalisation||$380.9 million|
TTM: trailing 12 months
ADMA Biologics share dividends
We're not expecting ADMA Biologics to pay a dividend over the next 12 months.
ADMA Biologics share price volatility
Over the last 12 months, ADMA Biologics's shares have ranged in value from as little as $1.01 up to $2.315. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ADMA Biologics's is 1.064. This would suggest that ADMA Biologics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
ADMA Biologics overview
ADMA Biologics, Inc. , a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers.
ADMA Biologics in the news
ADMA BioCenters Receives FDA Approval for its Sixth Plasma Collection Center, Located in Myrtle Beach, SC
Shareholders in ADMA Biologics (NASDAQ:ADMA) have lost 50%, as stock drops 12% this past week
ADMA Biologics Announces Addition to the Russell 2000® Index
Frequently asked questionsWhat percentage of ADMA Biologics is owned by insiders or institutions?
Currently 2.106% of ADMA Biologics shares are held by insiders and 67.223% by institutions. How many people work for ADMA Biologics?
Latest data suggests 527 work at ADMA Biologics. When does the fiscal year end for ADMA Biologics?
ADMA Biologics's fiscal year ends in December. Where is ADMA Biologics based?
ADMA Biologics's address is: 465 State Route 17, Ramsey, NJ, United States, 07446 What is ADMA Biologics's ISIN number?
ADMA Biologics's international securities identification number is: US0008991046 What is ADMA Biologics's CUSIP number?
ADMA Biologics's Committee on Uniform Securities Identification Procedures number is: 000899104
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert